Decentralized Trials: FDA Final Guidance Eliminates Need For Local Provider Activity Tracking

Draft recommendation for investigators to maintain a task log of activities that local health care providers perform was removed from final guidance on decentralized clinical trials. Other changes include more detail on US FDA oversight and what HCPs can and cannot do in such studies.